Latest Breaking News On - Mpox program - Page 1 : vimarsana.com

BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update

06.11.2023 - Positive clinical data updates across multiple drug classes including antibody-drug conjugate (ADC) candidates BNT323/DB-1303, BNT325/DB-1305, CAR-T candidate BNT211, T cell therapy candidate BNT221 and mRNA cancer vaccine candidate BNT116Progress .

United kingdomUnited statesSouth koreaFosun pharmaRoche tecentriqRegeneron libtayoBiontech fixvacUgur sahinJens holsteinGerman central bank deutsche bundesbankDuality biologics suzhou coMedilink therapeutics suzhou co ltdPfizer japan co ltdCoalition for epidemic preparedness innovationsRoche groupBiontech group

BioNTech SE: BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update

BioNTech SE: BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSouth koreaJens holsteinUgur sahinBiontech fixvacFosun pharmaRoche tecentriqRegeneron libtayoMpox programGerman central bank deutsche bundesbankDuality biologics suzhou coEuropean society of medical oncologyDays missionMedilink therapeutics suzhou co ltdRegeneron pharmaceuticals inc